Loading…

Measures of Retinal Structure and Function as Biomarkers in Neurology and Psychiatry

•Severe mental illnesses and many neurodegenerative disorders are characterized by thinning of retinal structures as indicated by optical coherence tomography (OCT) and by retinal dysfunction as indicated by electroretinography (ERG).•In many cases, studies indicate significant correlations between...

Full description

Saved in:
Bibliographic Details
Published in:Biomarkers in neuropsychiatry 2020-06, Vol.2, p.100018, Article 100018
Main Authors: Silverstein, Steven M., Demmin, Docia L., Schallek, Jesse B., Fradkin, Samantha I.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Severe mental illnesses and many neurodegenerative disorders are characterized by thinning of retinal structures as indicated by optical coherence tomography (OCT) and by retinal dysfunction as indicated by electroretinography (ERG).•In many cases, studies indicate significant correlations between retinal changes and clinical and neuropathological features such as cognitive decline, brain volume loss, overall illness severity, and progression of illness.•Retinal indices have the potential to serve as biomarkers of disease onset and progression, relapse, course, and treatment response.•Recent advances in imaging of retinal activity in vivo, and in data analysis techniques, have the potential to significantly improve the predictive validity of retinal measures. Investigators have increasingly turned to studying the retina as a window into brain structure and function. In neuropsychiatric diseases, retinal anatomy as assessed by optical coherence tomography (OCT) and retinal cell function as assessed by various forms of electroretinography (ERG) demonstrate notable changes. In addition, many studies indicate significant correlations between retinal changes and clinical features such as cognitive decline, overall illness severity, and progression of illness. Here, we review retinal findings in psychiatric (schizophrenia, autism, mood disorders, attention deficit hyperactivity disorder, anorexia nervosa), and neurologic (multiple sclerosis, Parkinson's disease, Alzheimer's disease and mild cognitive impairment, Huntington's disease, traumatic brain injury) conditions, in terms of their potential as biomarkers of disease onset, progression, severity, and outcomes. Consistency and variability in findings across studies are highlighted, and implications for future research are discussed. Potential confounds and methodological issues central to studies of retinal structure and function in neuropsychiatry are also considered. The review concludes with discussions of: a) recent advances in retinal imaging and their potential applications for studying brain disorders; and b) the potential for applications of artificial intelligence to increasing the predictive validity of retinal data.
ISSN:2666-1446
2666-1446
DOI:10.1016/j.bionps.2020.100018